Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biospecifics Tech Cp (NQ: BSTC )

88.53 USD UNCHANGED
Last Price Updated: 4:21 PM EST, Dec 1, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Biospecifics Tech Cp

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
The Daily Biotech Pulse: Foamix Jumps on Data, Positive Results for Galapagos-Gilead's Rheumatoid Arthritis Drug, Bausch Health Trims Debt
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... 
Tags KRYS CNST KALA
From Benzinga
The Daily Biotech Pulse: Advaxis Posts Narrower Loss, Endocyte Announces $175M Offering, Leadership Transition At Insulet
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Stocks that hit 52-week ... 
Tags PTX Offerings SSKN
From Benzinga
5 Top-Ranked Nasdaq Stocks Defying the Worst September Start
After peaking at the end of the last month, the Nasdaq Composite Index logged in the fourth straight decline last week, slumping 2.6% -- the worst start to September since 2008. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Biospecifics Tec Shares Up 26.0% Since SmarTrend's Buy Recommendation (BSTC)
SmarTrend identified an Uptrend for Biospecifics Tec (NASDAQ:BSTC) on March 12th, 2018 at $42.50. In approximately 6 months, Biospecifics Tec has returned 25.95% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
BioSpecifics Technologies Corp. to Present at Two Upcoming September Conferences
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed... 
From PR Newswire
IBD Stock Of The Day: Vertex Pharma Nears Third Breakout Of 2018
Vertex Pharmaceuticals is the IBD Stock Of The Day as shares near a breakout amid a flurry of recent news surrounding its cystic fibrosis treatments. 
From Investor's Business Daily
Market Trends Toward New Normal in Addus HomeCare, Sandstorm Gold, BioSpecifics Technologies, Itau Unibanco Holding S.A, Akers Biosciences, and Kosmos Energy — Emerging Consolidated Expectations, Anal
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Addus HomeCare Corporation... 
From GlobeNewswire News Releases
Biospecifics Tec Has Returned 22.0% Since SmarTrend Recommendation (BSTC)
SmarTrend identified an Uptrend for Biospecifics Tec (NASDAQ:BSTC) on March 12th, 2018 at $42.50. In approximately 5 months, Biospecifics Tec has returned 21.95% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
Biospecifics Technologies Joins Rank Of Stocks With 95-Plus Composite Rating
Biospecifics Technologies saw its IBD SmartSelect Composite Rating jump to 96 Tuesday, up from 92 the day before. 
From Investor's Business Daily
BioSpecifics Technologies Corp. Reports Second Quarter 2018 Financial Results
- Phase 1 trial of CCH for treatment of Uterine fibroids now fully enrolled - 
From PR Newswire
Biospecifics Technologies Corp. Breaks Below 200-Day Moving Average - Notable for BSTC
In trading on Friday, shares of Biospecifics Technologies Corp. (BSTC) crossed below their 200 day moving average of $43.42, changing hands as low as $43.06 per share.. 
Tags Stocks
From Market News Video
Investor Expectations to Drive Momentum within Capital Product Partners, Nova Measuring Instruments, BioSpecifics Technologies, Itau Unibanco Holding S.A., CNB Financial, and Laureate Education — Disc
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Capital Product Partners... 
From GlobeNewswire News Releases
Bullish Two Hundred Day Moving Average Cross - BSTC
In trading on Tuesday, shares of Biospecifics Technologies Corp. (BSTC) crossed above their 200 day moving average of $43.85, changing hands as high as $44.33 per share.. 
Tags Stocks
From Market News Video
Look Under The Hood: PXSG Has 13% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
BRIEF-Biospecifics Technologies Reports Q1 Earnings Per Share $0.54
* BIOSPECIFICS TECHNOLOGIES CORP. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS 
Tags companyNews
From Reuters: Company News
BioSpecifics Technologies Corp. Reports First Quarter 2018 Financial Results
- Continued year-over-year revenue growth for XIAFLEX - 
From PR Newswire
New Research: Key Drivers of Growth for Talend S.A, Chipmos Technologies, POSCO, Horizon Pharma Public, BioSpecifics Technologies, and Arbutus Biopharma — Factors of Influence, Major Initiatives and S
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Talend S.A. (NASDAQ:TLND),... 
From GlobeNewswire News Releases
Analysts Predict 17% Gains Ahead For PXSG
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
New Research: Key Drivers of Growth for CNB Financial, Akebia Therapeutics, Mesoblast, 21Vianet Group, Old Line Bancshares, and BioSpecifics Technologies — Factors of Influence, Major Initiatives and
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CNB Financial Corporation... 
From GlobeNewswire News Releases
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2017 Financial Results
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed... 
From PR Newswire
BioSpecifics Technologies Corp. Announces Presentation of Interim Data from Phase 1 Study of CCH for the Treatment of Uterine Fibroids at 65th Annual Scientific Meeting of the Society for Reproductive
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed... 
From PR Newswire
How The Parts Add Up: PXSG Headed For $39
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Biospecifics Tec Down 15.7% Since SmarTrend Downtrend Call (BSTC)
SmarTrend identified a Downtrend for Biospecifics Tec (NASDAQ:BSTC) on August 10th, 2017 at $46.31. In approximately 6 months, Biospecifics Tec has returned 15.73% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
BioSpecifics Technologies Corp. to Present at the NobleCon14 Conference
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed... 
From PR Newswire
BRIEF-Biospecifics Technologies reports Q3 eps of $0.37
* Biospecifics Technologies Corp reports Q3 2017 financial results 
Tags companyNews
From Reuters: Company News
BioSpecifics Technologies Corp. Reports Third Quarter 2017 Financial Results
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed... 
From PR Newswire
BioSpecifics Technologies Corp. to Present at the Stifel 2017 Healthcare Conference
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed... 
From PR Newswire
Analysts Anticipate PXSG To Hit $36
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
BioSpecifics Technologies Corp. to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed... 
From PR Newswire
BioSpecifics Technologies Corp. to Present at Two Upcoming September Conferences
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed... 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.